T-Cell Densities in Brain Metastases Are Associated with Patient Survival Times and Diffusion Tensor MRI Changes

Rasheed Zakaria1,2, Angela Platt-Higgins2, Nitika Rathi3

  • 1Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom. rzakaria@nhs.net.

Cancer Research
|December 8, 2017
PubMed

Insights

Diffusion tensor imaging (DTI) reveals white matter tract disruption near brain metastases. Lower fractional anisotropy (FA) independently predicts longer survival, correlating with T-cell infiltration, offering a noninvasive immune microenvironment assessment.

Area of Science:

  • Neuroimaging
  • Oncology
  • Immunology

Background:

  • Brain metastases are frequent and typically diagnosed via MRI.
  • Diffusion tensor imaging (DTI) is an advanced MRI technique sensitive to white matter tract integrity.
  • Understanding the brain-tumor interface is crucial for predicting patient outcomes.

Purpose of the Study:

  • To investigate the relationship between white matter tract integrity, measured by DTI, and the biological characteristics of the brain-tumor interface.
  • To determine if DTI metrics can predict survival in patients with brain metastases.
  • To assess the correlation between T-cell infiltration and DTI parameters.

Main Methods:

  • Preoperative DTI was performed on 26 patients undergoing brain metastasis resection.
  • Image-guided sampling of the brain-tumor interface assessed mean diffusivity and fractional anisotropy (FA).
  • Tissue samples were analyzed for vascularity, inflammatory cells (CD3+ lymphocytes), and tumor markers (Ki67, S100A4, MMPs).

Main Results:

  • Lower FA in the peritumoral region indicated greater white matter tract disruption.
  • Reduced FA independently predicted longer overall survival (HR=0.21, P=0.024).
  • Increased CD3+ lymphocyte density correlated with decreased FA (P=0.037) and confounded FA's survival effect.

Conclusions:

  • White matter tract integrity, assessed by DTI, is compromised by T-cell infiltration at the brain-tumor interface.
  • DTI provides a noninvasive method to identify an active immune microenvironment in brain metastases.
  • This approach may help assess immunotherapy susceptibility and patient prognosis.

Related Concept Videos